Twinrix vaccine syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F8E8C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,775
Award facts
- Contract value 100% obligated
- $10,775.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for the supply of Twinrix vaccine in syringe format. This competitive award, valued at $10,775.35 with firm fixed pricing, is not designated as a set-aside contract and will be completed by January 27, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, an expansive $999,999,999.00 vehicle extending through December 2031 that serves as the primary mechanism for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This contract exemplifies the critical role pharmaceutical distributors play in federal medical procurement, particularly for the Department of Defense medical supply chain. The Twinrix vaccine delivery supports military treatment facilities and defense healthcare operations through a streamlined acquisition process. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its proven capability to compete successfully in open procurement and efficiently fulfill government requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F8E8C?
SPE2DR26F8E8C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F8E8C worth?
The government has obligated $10,775 on SPE2DR26F8E8C.
Is contract SPE2DR26F8E8C an order under another contract?
Yes. SPE2DR26F8E8C is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E8C competed?
The extent of competition for SPE2DR26F8E8C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award